HSBC set a €75.00 ($87.21) price objective on Carl Zeiss Meditec (ETR:AFX) in a research report released on Tuesday morning. The firm currently has a buy rating on the stock.

Several other brokerages also recently commented on AFX. Hauck & Aufhaeuser set a €69.00 ($80.23) target price on Carl Zeiss Meditec and gave the company a neutral rating in a report on Tuesday, August 21st. Nord/LB set a €62.00 ($72.09) target price on Carl Zeiss Meditec and gave the company a sell rating in a report on Tuesday, September 4th. Deutsche Bank set a €65.00 ($75.58) target price on Carl Zeiss Meditec and gave the company a neutral rating in a report on Tuesday, August 14th. Independent Research set a €73.00 ($84.88) target price on Carl Zeiss Meditec and gave the company a neutral rating in a report on Monday, August 13th. Finally, Kepler Capital Markets set a €62.00 ($72.09) target price on Carl Zeiss Meditec and gave the company a sell rating in a report on Monday, August 27th. Three research analysts have rated the stock with a sell rating, five have given a hold rating and one has issued a buy rating to the stock. Carl Zeiss Meditec currently has an average rating of Hold and an average price target of €65.88 ($76.60).

Shares of Carl Zeiss Meditec stock opened at €66.70 ($77.56) on Tuesday. Carl Zeiss Meditec has a fifty-two week low of €37.53 ($43.64) and a fifty-two week high of €55.25 ($64.24).

About Carl Zeiss Meditec

Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.

Featured Article: Return on Investment (ROI) Defined, Explained

Analyst Recommendations for Carl Zeiss Meditec (ETR:AFX)

Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.